April 26, 2024

Strong sell off starts week

Index & Sector performance 2/3/14 The Market:   In the News:     The following noteworthy companies are scheduled to report earnings before tomorrow’s open: EMR, ETN, ADM, CME, SE, HCA, SIRI, IP, BDX, MHFI, DLPH, BSX, KORS, FIS, CLX, AMG, SEP   Analyst Comments:         The Game Plan:

Do you buy the dip?

Index & Sector performance 1/28/14 The Market: In the overnight session the futures managed to recover gaining nearly 20 points from Monday’s lows.  When the Durables number was announced and came in much worse than expected the market puled back challenging support but that support held and by the open the market was back near the pre-market highs.  The remainder of the day the S&P 500 stayed in a relatively tight trading range with all of the major indices closing higher. In Economic news the Durable Goods numbers came in much worse than expected with Core Durable Goods Orders posting…

Slow grind higher continues

Index & Sector performance 12/9/13 The Market: Another slow grinding day with a bias higher.  It is yet to be seen if this is a consolidation for a next leg higher or exhaustion with a leg lower to come.  To catch the most amount of people off guard the market could look to pop higher first to finish and then start a strong quick decline. There was no economic data today but there was Fed speak from FOMC member Bullard.  Bullard was a QE3 supporter and noted his stance that any Fed action is data dependent.  The increase in jobs…

Daily Wrap

DJIA +21.05 (+0.14%) to 14,839.80; S&P 500 +3.96 (+0.25%) to 1,597.57; NASDAQ +20.49 (+0.71%) to 2,887.44 Today saw some jockeying for position by the indices as they started the day moving lower and then recovered to close slightly up for the session.  In economic news the Case/Shiller index rose 1.2% from the previous month’s reading and topped estimates with a 9.3% vs 9.1% estimate.  Chicago PMI on the other hand fell short of estimates recording a 49 vs 52.5 estimate.  Consumer confidence came in mainly inline with a 68.1 vs 68.4 estimate. Before the open, Pfizer (PFE) reported earnings which missed on both revenues ($13.5B vs $14B) and EPS (54c…